About
Harmony Biosciences Holdings (NASDAQ:HRMY) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026
Apr 16 2026
Harmony Biosciences to Present Open-Label Extension Data From Phase 3 ARGUS Trial at the 2026 American Academy of Neurology Annual Meeting
Apr 14 2026
Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer
Apr 2 2026
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board
Mar 31 2026
Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference
Financials
Revenue
$868.45 M
Market Cap
$1.69 B
P/E Ratio
10.76
EPS
2.71
Translate